Arcutis Biotherapeutics, Inc. ARQT Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| —— | —— | -$44.32M+77.3% | -$93.27M+53.1% | -$129.72M+40.3% | ||
| $41.28M-0.5% | $40.36M-3.3% | $39.7M-3.4% | $39.44M-4.5% | $41.48M+5.4% | ||
| —— | —— | —— | —— | -$110.94M+44.1% | ||
| —— | —— | —— | $829K+1,084% | $751K+117% | ||
| -$53.34M-177% | -$30.25M-205% | $38.8M— | $148.83M— | $69.27M— | ||
| —— | $0-100% | $25M-66.7% | $50M0.0% | $75M+200% | ||
| $7.65M— | $6.97M— | —— | —— | —— | ||
| -$18.65M+86.4% | -$28.74M-65.4% | -$88.04M— | -$11.84M— | -$136.99M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Arcutis Biotherapeutics, Inc. generate?
- Arcutis Biotherapeutics, Inc. (ARQT) generated -$30.6M in operating cash flow over the trailing twelve months.
- What is Arcutis Biotherapeutics, Inc.'s free cash flow?
- After $686.0K of capital expenditures, Arcutis Biotherapeutics, Inc.'s free cash flow was -$31.3M over the trailing twelve months, up 81.4% year over year.
- Where does Arcutis Biotherapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Arcutis Biotherapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
